SIC
NVCT icon

SJS Investment Consulting’s Nuvectis Pharma NVCT Stock Holding History

SJS Investment Consulting’s Portfolio NVCT Stock Details NVCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$74 Buy
+4
New +$45 ﹤0.01% 2663

Other funds holding NVCT

BWP
Baldwin Wealth Partners Marion, Massachusetts $1.53B AUM 28.5% 1-Year Est. Return
JMFC
J.M. Forbes & Co Boston, Massachusetts $1.27B AUM 26.46% 1-Year Est. Return
AWM
Austin Wealth Management Austin, Texas $473M AUM 18.73% 1-Year Est. Return
NS
NBC Securities Birmingham, Alabama $1.48B AUM 31.07% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $420M AUM 22.7% 1-Year Est. Return

SJS Investment Consulting's NVCT Position: Q2 2026 in Review

SJS Investment Consulting opened a new position in Nuvectis Pharma (NVCT) in Q2 2026: 4 shares worth $74. The stake represents ﹤0.01% of the portfolio and ranks #2663 among its holdings.

9 funds tracked by Wall St. Rank hold NVCT as of Q2 2026.

  • SJS Investment Consulting held 4 shares of Nuvectis Pharma worth $74 as of Q2 2026.
  • Nuvectis Pharma was a new SJS Investment Consulting position in Q2 2026.
  • Nuvectis Pharma made up ﹤0.01% of SJS Investment Consulting's portfolio in Q2 2026, its #2663 holding.
  • 9 funds tracked by Wall St. Rank held Nuvectis Pharma as of Q2 2026.

Based on SJS Investment Consulting's 13F filing for Q2 2026, filed 22 Jul 2026.